tiprankstipranks
Trending News
More News >
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market
Advertisement

PharmAla Biotech Holdings, Inc. (MDMA) Revenue

Compare
60 Followers

PharmAla Biotech Holdings, Inc. Revenue

PharmAla Biotech Holdings, Inc. had a revenue of 145.66K in the quarter ending Mar 31, 2025, with 154.21%. This bring the company's revenue in the last twelve months to 342.80K, Decreased 19.21%. In the fiscal year ending Sep 30, 2024, PharmAla Biotech Holdings, Inc. had annual revenue of 1.04M with 94.60% growth.
Revenue (ttm)
342.80K
Revenue Growth
-69.15%
P/S Ratio
10.21
Revenue/Employee
Employees
Market Cap
C$10.57M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Sep 30, 2024
1.04M503.29K+94.60%
Sep 30, 2023
532.00K453.93K+581.44%
Sep 30, 2022
78.07K+∞%
Sep 30, 2021
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis